Selected Adverse Reactions in cSSSI

Incidence of adverse reactions that occurred in 2% of adult patients in the CUBICIN®(daptomycin for injection) treatment group and ≥ the comparator treatment group in Phase 3 cSSSI trials

Event PERCENTAGE OF ADULT PATIENTS (%)
CUBICIN (n=534) Comparatora (n=558)
Diarrhea 5.2 4.3
Headache 5.4 5.4
Dizziness 2.2 2.0
Rash 4.3 3.8
Abnormal LFT 3.0 1.6
Elevated CPK 2.8 1.8
Urinary tract infection 2.4 0.5
Hypotension 2.4 1.4
Dyspnea 2.1 1.6
  1. Vancomycin or semisynthetic penicillin.

Learn about the mechanism of action of CUBICIN® (daptomycin for injection). »